/

Other

/

Serb Pharmaceuticals

Serb Pharmaceuticals

Serb Pharmaceuticals

Verified Nov 2026

Other

·

Brussels, Brussels

·

Since 1951

SERB Pharmaceuticals is a specialty pharmaceutical company founded in 1951 and headquartered in Brussels, Belgium. With 500–1,000 employees and estimated revenue of $100–250 million, the privately held firm develops and manufactures essential medicines for critical care, medical emergencies, and rare diseases. The company operates in over 100 countries and recently acquired European and Middle Eastern/North African rights to imlifidase, a treatment for organ transplant rejection.

Serb Pharmaceuticals

Verified Nov 2026

AT A GLANCE

Founded

1951

Headquarters

Brussels, Brussels

Employees

500-1,000

Ownership

Serb Pharmaceuticals at a glance

Revenue

$100-250M

Est. band

Employees

500-1,000

Founded

1951

Headquarters

Brussels, Brussels

Industries

Automotive

Electric Vehicles

Medical

Industrial Equipment

Overview

SERB Pharmaceuticals is a specialty pharmaceutical company founded in 1951 and headquartered in Brussels, Belgium. With 500–1,000 employees and estimated revenue of $100–250 million, the privately held firm develops and manufactures essential medicines for critical care, medical emergencies, and rare diseases. The company operates in over 100 countries and recently acquired European and Middle Eastern/North African rights to imlifidase, a treatment for organ transplant rejection.

At a glance

Attribute

Detail

Founded

1951

Headquarters

Brussels, Brussels

Employees

500-1,000

Revenue

$100-250M (estimated)

What Serb Pharmaceuticals makes

SERB specializes in niche-branded prescription drugs, antidotes for medical emergencies, and rare disease treatments, with a focus on critical care and biologic manufacturing capabilities.

Products and capabilities described on the company's own site include Emissions, Seal (source: serb.com).

Latest developments

Facilities

Serb Pharmaceuticals is headquartered in Brussels, Brussels. Public sources also reference these locations:

Company details

The privately owned group operates across over 100 countries and serves healthcare providers, government agencies, and emergency responders through a global sales network. Serb Pharmaceuticals was founded in 1951, has an estimated 500-1,000 employees, and is headquartered in Brussels, Brussels.

Frequently asked questions

What does Serb Pharmaceuticals do?

SERB Pharmaceuticals is a specialty pharmaceutical company founded in 1951 and headquartered in Brussels, Belgium. With 500–1,000 employees and estimated revenue of $100–250 million, the privately held firm develops and manufactures essential medicines for critical care, medical emergencies, and rare diseases. The company operates in over 100 countries and recently acquired European and Middle Eastern/North African rights to imlifidase, a treatment for organ transplant rejection.

Where is Serb Pharmaceuticals headquartered?

Serb Pharmaceuticals is headquartered in Brussels, Brussels (480 Avenue Louise, Brussels, Brussels, 1050).

When was Serb Pharmaceuticals founded?

Serb Pharmaceuticals was founded in 1951.

How big is Serb Pharmaceuticals?

Serb Pharmaceuticals has an estimated 500-1,000 employees, with revenue in the $100-250M range (estimated).

Related suppliers

Explore other suppliers in the LightSource directory:

Last verified Nov 2026. Is this your company? Request a correction.

Location & contact

Brussels, Brussels (HQ)Headquarters · Belgium
Brussels, Brussels (HQ)480 Avenue Louise, Brussels, Brussels, 1050, BelgiumHeadquarters

Evaluating suppliers like these?

This profile is part of a public-data sample of the full LightSource directory. Book a demo to see the full LightSource marketplace and supplier discovery platform — 1M+ credible suppliers, with AI-run sourcing events.